Site landscape shrinking, losing most active PIs
High turnover and influx of novices plague site workforce
Social media has sponsors losing control of their message
As industry awaits guidance from FDA, patients blogging about their trial experiences
UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, marketing products in more than 40 countries. Revenue in 2010 was $4.3 billion, and the company has more than 8,500 employees and strategic partnerships with key pharmaceutical companies. Its international research and development organization includes UCB New Medicines and UCB Global Projects and Development.